Hanmi Science Co., Ltd. Overview
Pro stress-test →Hanmi Science is a holding company with two core subsidiaries: Hanmi Pharmaceutical, which develops and produces medicines, and Online Pharm, a drug wholesaler. The company develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics.
Strategic Profile
Pro stress-test →The company operates through its pharmaceutical manufacturing subsidiary and drug distribution network, actively developing new drugs in recent years. Hanmi recently partnered with Merck & Co on April 4, 2024, demonstrating its strategic focus on expanding its drug development pipeline and global partnerships.
Competitive Landscape
Pro stress-test →Hanmi Science competes in the South Korean and broader Asian pharmaceutical market against multinational pharma giants and local competitors. Its competitive advantage lies in specialized therapeutic areas (diabetes, oncology, GI) and a vertically integrated distribution model through Online Pharm. The company faces competition from larger multinational players with greater R&D budgets and global reach.
Industry Context
Hanmi Science Co., Ltd. operates in Pharmaceuticals and Healthcare.
Key facts
Founded: 1973 · Headquarters: Seoul, South Korea · Employees: 422 · Revenue: $941.7M · Market cap: $1.72B